Ownership history in BARCLAYS PLC · 17 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 80,784 | -11,342 | -12.3% | 0.00% | $6.6M | $81.88 |
| 2025 Q3 | ADDED | 92,126 | +79,426 | +625.4% | 0.00% | $5.5M | $59.43 |
| 2025 Q3 | REDUCED | 12,700 | -114,879 | -90.0% | 0.00% | $755K | $59.43 |
| 2025 Q2 | ADDED | 127,579 | +74,740 | +141.4% | 0.00% | $5.2M | $40.51 |
| 2025 Q1 | REDUCED | 52,839 | -21,825 | -29.2% | 0.00% | $2.7M | $51.37 |
| 2024 Q4 | REDUCED | 74,664 | -23,999 | -24.3% | 0.00% | $4.1M | $55.37 |
| 2024 Q3 | ADDED | 98,663 | +76,538 | +345.9% | 0.00% | $3.2M | $32.89 |
| 2024 Q2 | REDUCED | 22,125 | -8,183 | -27.0% | 0.00% | $600K | $27.18 |
| 2024 Q1 | REDUCED | 30,308 | -16,951 | -35.9% | 0.00% | $1.1M | $36.35 |
| 2023 Q4 | ADDED | 47,259 | +35,622 | +306.1% | 0.00% | $957K | $20.25 |
As of 2025 Q4 — sorted by position size